A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20347484.
- Also identified by DOI 10.1016/j.biomaterials.2010.03.008 and PMC identifier 3072837.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here we develop an injectable composite system based for repeated ultrasound-triggered on-demand drug delivery. An in situ-cross-linking hydrogel maintains model drug (dye)-containing liposomes in close proximity to gas-filled microbubbles that serve to enhance release events induced by ultrasound application. Dye release is tunable by varying the proportions of the liposomal and microbubble components, as well as the duration and intensity of the ultrasound pulses in vitro. Dye is minimal at baseline. The composite shows minimal cytotoxicity in vitro, and benign tissue reaction after subcutaneous injection in rats. Ultrasound application also triggers drug release for two weeks after injection in vivo.
Medical subject headings
- Hydrogels
- Liposomes
- Sonication